Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06452823

Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization

Sponsor: The Second Affiliated Hospital of Jiaxing University

View on ClinicalTrials.gov

Summary

Patients with hyperthyroidism or hypothyroidism are often combined with atrial fibrillation, but after the stabilization of thyroid hormone levels after treatment, the patients' atrial fibrillation still persists. Radiofrequency ablation of the atrial fibrillation as one of the treatment options for atrial fibrillation has been widely used in the clinic, and has significant efficacy in maintaining sinus rhythm, improving cardiac function, and improving the prognosis of patients. However, there is a lack of clinical monitoring data on radiofrequency ablation of atrial fibrillation in patients who have combined thyroid dysfunction and have stabilized their thyroid hormone levels after treatment.

Official title: Cardiovascular Medicine Department of Second Affiliated Hospital of Jiaxing University

Key Details

Gender

All

Age Range

45 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2024-05-01

Completion Date

2026-06-30

Last Updated

2024-06-11

Healthy Volunteers

No

Interventions

PROCEDURE

Catheter Ablation

catheter radiofrequency ablation therapy for atrial fibrillation involves the use of ablative energy to destroy the cardiomyocytes at the opening of the pulmonary veins, which blocks the electrical conduction pathway between the pulmonary veins and the left atrium, so that atrial fibrillation no longer occurs.

Locations (1)

Cardiovascular Medicine Department of Second Affiliated Hospital of Jiaxing University

Jiaxing, Zhejiang, China